Stable isotopes in the diagnosis and treatment of inherited hyperammonemia

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Pediatric Biochemistry

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0036-1586461PMID 24634704PMCID PMC3952002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of N-acetylglutamate synthase by various monocarboxylic and dicarboxylic short-chain coenzyme A esters and the production of alternative glutamate esters.

  2014cited by this paper
• Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genome.

  2012cited by this paper
• Short-term outcome of propionic aciduria treated at presentation with N-carbamylglutamate: a retrospective review of four patients.

  2012cited by this paper
• Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations

  2011cited by this paper
• N‐carbamylglutamate enhancement of ureagenesis leads to discovery of a novel deleterious mutation in a newly defined enhancer of the NAGS gene and to effective therapy

  2011cited by this paper
• Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects.

  2010cited by this paper
• Liver cell transplantation in children

  2009cited by this paper
• N-Carbamylglutamate in Emergency Management of Hyperammonemia in Neonatal Acute Onset Propionic and Methylmalonic Aciduria

  2009cited by this paper
• Biochemical efficacy of N-carbamylglutamate in neonatal severe hyperammonaemia due to propionic acidaemia

  2009cited by this paper
• N-Carbamylglutamate for neonatal hyperammonaemia in propionic acidaemia

  2008cited by this paper
• N-carbamylglutamate Markedly Enhances Ureagenesis in N-acetylglutamate Deficiency and Propionic Acidemia as Measured by Isotopic Incorporation and Blood Biomarkers

  2008cited by this paper
• Cross-sectional multicenter study of patients with urea cycle disorders in the United States.

  2008cited by this paper
• Adult-Derived Human Liver Mesenchymal-Like Cells as a Potential Progenitor Reservoir of Hepatocytes?

  2007cited by this paper
• Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors.

  2006cited by this paper
• Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene

  2006cited by this paper
• N-Carbamylglutamate protects patients with decompensated propionicaciduria from hyperammonaemia

  2005cited by this paper
• Untersuchungen über die Harnstoffbildung im Tierkörper

  2005cited by this paper
• The end-product method of measuring whole-body protein turnover: a review of published results and a comparison with those obtained by leucine infusion

  2005cited by this paper
• Restoration of ureagenesis in N-acetylglutamate synthase deficiency by N-carbamylglutamate.

  2004cited by this paper
• Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency

  2004cited by this paper
• Isotope Tracers in Metabolic Research: Principles and Practice of Kinetic Analysis

  2004cited by this paper
• An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency.

  2002influential reference
• Proceedings of a consensus conference for the management of patients with urea cycle disorders.

  2001cited by this paper
• Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype.

  2000cited by this paper
• In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle.

  2000cited by this paper
• Applied gas chromatography coupled to isotope ratio mass spectrometry.

  1999cited by this paper
• Use of gas chromatography-combustion-isotope ratio mass spectrometry in nutrition and metabolic research.

  1999cited by this paper
• The use of stable isotope techniques for nutritional and metabolic research in paediatrics.

  1998cited by this paper
• Urea cycle disorders: diagnosis, pathophysiology, and therapy.

  1996cited by this paper
• In vivo nitrogen metabolism in ornithine transcarbamylase deficiency.

  1996cited by this paper
• Mass spectrometric analysis of stable-isotope-labelled amino acid tracers

  1994cited by this paper
• Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies.

  1984cited by this paper
• Response of Protein and Urea Kinetics in Burn Patients to Different Levels of Protein Intake

  1983cited by this paper
• Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion.

  1982cited by this paper
• Treatment of hyperammonemic coma caused by inborn errors of urea synthesis.

  1980cited by this paper
• Failure of the normal ureagenic response to amino acids in organic acid-loaded rats. Proposed mechanism for the hyperammonemia of propionic and methylmalonic acidemia.

  1980cited by this paper
• Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia.

  1979cited by this paper
• Effect of Propionic Acid on Fatty Acid Oxidation and Ureagenesis

  1976cited by this paper
• A study of the rate of protein synthesis in humans. I. Measurement of the urea pool and urea space.

  1953cited by this paper
• A study of the rate of protein synthesis in humans. II. Measurement of the metabolic pool and the rate of protein synthesis.

  1953cited by this paper
• The dynamic state of body constituents.

  1942cited by this paper
• The Dynamic State of Body Constituents

  1942cited by this paper
• THE APPLICATION OF THE NITROGEN ISOTOPE N15 FOR THE STUDY OF PROTEIN METABOLISM.

  1938cited by this paper
• THE APPLICATION OF ISOTOPES TO THE STUDY OF INTERMEDIARY METABOLISM.

  1938cited by this paper

• Characterization and treatment monitoring of ureagenesis disorders using stable isotopes

  2025cites this paper
• Wearable respiratory sensors for health monitoring

  2024cites this paper
• 1-13C-propionate breath testing as a surrogate endpoint to assess efficacy of liver-directed therapies in methylmalonic acidemia (MMA)

  2021cites this paper
• Primary Hyperammonaemia: Current Diagnostic and Therapeutic Strategies

  2020cites this paper
• Comprehensive characterization of ureagenesis in the spfash mouse, a model of human ornithine transcarbamylase deficiency, reveals age‐dependency of ammonia detoxification

  2019cites this paper
• Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder

  2017cites this paper
• A simple dried blood spot-method for in vivo measurement of ureagenesis by gas chromatography-mass spectrometry using stable isotopes.

  2017cites this paper
• Historical and contemporary stable isotope tracer approaches to studying mammalian protein metabolism

  2016cites this paper
• Concise Review: Updated Advances and Current Challenges in Cell Therapy for Inborn Liver Metabolic Defects

  2016cites this paper
• Clinical experience with N-carbamylglutamate in a single-centre cohort of patients with propionic and methylmalonic aciduria

  2016cites this paper
• In vivo monitoring of urea cycle activity with (13)C-acetate as a tracer of ureagenesis.

  2016cites this paper
• Minimal ureagenesis is necessary for survival in the murine model of hyperargininemia treated by AAV-based gene therapy

  2015cites this paper
• Metabolism of Albumin after Continuous Venovenous Hemofiltration in Patients with Systemic Inflammatory Response Syndrome

  2015cites this paper
• Minimal Ureagenesis is Necessary for Survival in the Murine Model of Hyperargininemia Treated by AAV-based Gene Therapy

  2014cites this paper